Search Results - "Rowe, Steven P."

An Automated Deep Learning-Based Framework for Uptake Segmentation and Classification on PSMA PET/CT Imaging of Patients with Prostate Cancer.

Authors: Li, Yang Imami, Maliha R. Zhao, Linmei et al.

Source: Journal of Digital Imaging; Oct2024, Vol. 37 Issue 5, p2206-2215, 10p

Increases in the Association Between the Rates of Synchronous and Metachronous Metastases over Time †.

Authors: Yilmaz, Ugur Rowe, Steven P. Marks, Lawrence B.

Source: Journal of Clinical Medicine. Apr2025, Vol. 14 Issue 8, p2762. 11p.

SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization.

Authors: Rowe, Steven P. Shuch, Brian M. Ball, Mark W. et al.

Source: Journal of Nuclear Medicine. Dec2025, Vol. 66 Issue 12, p1863-1870. 8p.

Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma.

Authors: Novruzov, Emil Mamlins, Eduards Widjaja, Liam et al.

Source: Journal of Nuclear Medicine. May2026, Vol. 67 Issue 5, p687-692. 6p.

Rate of unspecific bone uptake on PSMA PET is determined by the Scaffold – not the Radionuclide. Letter regarding: "The homunculus of unspecific bone uptakes associated with PSMA- targeted tracers: a systematic review-based definition" and "Cutting back on overdiagnosis – Occam's razor and unspecific bone uptakes in PSMA PET"

Authors: Rowe, Steven P. Gorin, Michael A.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2024, Vol. 51 Issue 12, p3767-3768. 2p.

Erdheim-Chester Disease Occult on Radiographs and CT but Visible on MRI and PET.

Authors: Kim, Minsoo Rowe, Steven P. Mehta, Tej I.

Source: American Journal of Case Reports. 3/30/2024, p1-6. 6p.

Real-Time Imaging of ¹⁷⁷Lu-Labeled Radiopharmaceutical Infusions with a Portable γ-Camera: Pilot Trial Results.

Authors: Oldan, Jorge D. Schroeder, Jennifer A. Khandani, Amir et al.

Source: Journal of Nuclear Medicine Technology. Mar2026, Vol. 54 Issue 1, p55-58. 4p.

Phase 1 Study of [¹⁷⁷Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.

Authors: Mittra, Erik S. Solnes, Lilja B. van der Veldt, Astrid A.M. et al.

Source: Journal of Nuclear Medicine. Feb2026, Vol. 67 Issue 2, p262-268. 7p.

Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET.

Authors: Leung, Kevin H. Rowe, Steven P. Leal, Jeffrey P. et al.

Source: EJNMMI Research. 12/29/2022, Vol. 12 Issue 1, p1-15. 15p.

The use of ^99mTc‐tetrofosmin in the characterisation of indeterminate renal masses: a pilot study.

Authors: Spiro, Ergi Murtazaliev, Salikh Amindarolzarbi, Alireza et al.

Source: BJU International. Dec2024, Vol. 134 Issue 6, p929-931. 3p.

Redefining AT1 Receptor PET Imaging: Introducing the Radiotracer [ 18 F]DR29.

Authors: Chen, Xinyu Kimura, Hiroyuki Sasaki, Takanori et al.

Source: Hypertension (0194911X). Oct2025, Vol. 82 Issue 10, p1626-1637.

A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinoma.

Authors: Voter, Andrew F. Amindarolzarbi, Alireza Shen, Colette J. et al.

Source: Scientific Reports. 5/16/2025, Vol. 15 Issue 1, p1-7. 7p.

Inhibition of Mitochondrial-Associated Protein MAGMAS Resensitizes Chemoresistant Prostate Cancer Cells to Docetaxel.

Authors: Durán, Alfonso M. Whitley, Kristen Santiago, Krystal et al.

Source: Cancers. May2025, Vol. 17 Issue 9, p1535. 15p.

PET-Based Outcome Prediction in Patients with Prostate Cancer Scheduled for [²²⁵Ac]Ac-PSMA Radiopharmaceutical Therapy.

Authors: Widjaja, Liam Siegmund, Sophie C. Gildehaus, Franz J. et al.

Source: Journal of Nuclear Medicine. Apr2026, Vol. 67 Issue 4, p568-575. 8p.

Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein–Targeted Imaging—FAP-RADS Version 1.0.

Authors: Novruzov, Emil Sheikh, Gabriel T. Mamlins, Eduards et al.

Source: Journal of Nuclear Medicine. Aug2025, Vol. 66 Issue 8, p1245-1251. 7p.

Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [ 124 I]FIAU PET/CT.

Authors: Cho, Steve Y. Rowe, Steven P. Jain, Sanjay K. et al.

Source: Molecular Imaging. 6/29/2020, Vol. 19, p1-9. 9p.

Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and Prognosis of Cancer on PET/CT.

Authors: Leung, Kevin H. Rowe, Steven P. Sadaghiani, Moe S. et al.

Source: Journal of Nuclear Medicine. Apr2024, Vol. 65 Issue 4, p643-650. 8p.

Imager-4D: New Software for Viewing Dynamic PET Scans and Extracting Radiomic Parameters from PET Data.

Authors: Rowe, Steven P. Solnes, Lilja B. Yin, Yafu et al.

Source: Journal of Digital Imaging; Dec2019, Vol. 32 Issue 6, p1071-1080, 10p, 1 Diagram, 4 Graphs

Preoperative PSMA‐targeted PET imaging: more than just a tool for prostate cancer staging?

Authors: Meyer, Alexa R. Rowe, Steven P. Gorin, Michael A.

Source: BJU International. Jul2019, Vol. 124 Issue 1, p2-3. 2p.

CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET.

Authors: Sharma, Ajay Kumar Gupta, Kuldeep Mishra, Akhilesh et al.

Source: Advanced Science; Apr2024, Vol. 11 Issue 16, p1-13, 13p